Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices, Continuous Glucose Monitoring Devices, Insulin Pumps, Smart Diabetes Management Devices, Lancets and Lancing Devices, Glucometers), By End-User Industry (Hospitals and Clinics, Homecare Settings, Diagnostic Centers, Diabetes Care Centers), By Technology (Wearable Devices, Non-invasive Devices, Smart Glucose Monitors, Connected Diabetes Devices), and By Distribution Channel (Online Sales, Retail Pharmacies, Hospitals and Clinics, Diabetes Care Centers); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Diabetes Care Devices Market was valued at USD 41.6 billion in 2023 and will surpass USD 87.4 billion by 2030; growing at a CAGR of 11.2% during 2024 - 2030.

The global diabetes care devices market has experienced significant growth over the past few years, driven by the rising prevalence of diabetes worldwide, increased awareness of diabetes management, and technological advancements in diabetes care devices. Diabetes care devices help patients effectively manage their condition by offering solutions for monitoring blood glucose levels, administering insulin, and providing real-time data to optimize diabetes treatment. With the market expected to expand further due to the increasing adoption of advanced healthcare technologies, this market represents a significant opportunity for manufacturers and innovators in the healthcare sector.

The market is characterized by a diverse range of products and solutions, each addressing different aspects of diabetes care. This includes blood glucose monitoring devices, insulin delivery systems, continuous glucose monitoring devices, and insulin pumps. Additionally, advancements in wearable technology, non-invasive glucose monitoring, and smart diabetes management solutions are reshaping the landscape of diabetes care, offering patients greater control and flexibility over their treatment regimens. The following sections examine key segments within this growing market, focusing on the largest and fastest-growing subsegments.

Blood Glucose Monitoring Devices Segment Is Largest Owing To Wide Adoption

The blood glucose monitoring devices segment is the largest within the diabetes care devices market. This segment includes devices such as glucometers and test strips, which are essential tools for diabetes management. Blood glucose monitoring is a fundamental part of diabetes care, allowing patients to measure their blood sugar levels regularly to make necessary adjustments to their diet, exercise, and medication. Due to the essential nature of these devices for both Type 1 and Type 2 diabetes patients, the blood glucose monitoring subsegment maintains a dominant share in the market.

The growth of this segment is driven by the increasing global prevalence of diabetes and the growing awareness about the importance of regular blood glucose monitoring. With widespread use in both homecare settings and clinical environments, the demand for easy-to-use, affordable, and accurate blood glucose monitors continues to rise. Additionally, manufacturers are continuously improving device accuracy, user-friendliness, and connectivity with mobile applications, further enhancing the adoption of these devices across diverse patient populations.

Insulin Delivery Devices Segment Is Fastest Growing Owing To Technological Advancements

The insulin delivery devices segment is experiencing the fastest growth in the diabetes care devices market, fueled by technological innovations that enhance the efficiency and convenience of insulin administration. Insulin delivery devices, including insulin pens, syringes, and insulin pumps, are critical for managing diabetes by providing precise insulin dosages based on the patient’s needs. Among these, insulin pumps are the fastest-growing subsegment, thanks to advancements in wearable technology, smart insulin pumps, and automated insulin delivery systems.

Insulin pumps offer a major advantage over traditional insulin injections by providing continuous, real-time insulin administration, mimicking the natural insulin release of the pancreas. The growing adoption of insulin pumps, especially in developed markets, is driven by their ability to improve glycemic control and reduce the burden of multiple daily injections. Additionally, the integration of advanced features such as Bluetooth connectivity, integration with continuous glucose monitors (CGMs), and automatic insulin adjustments are boosting the popularity and growth of this subsegment.

Continuous Glucose Monitoring Devices Segment Is Largest Owing To Real-Time Data Accuracy

Continuous glucose monitoring (CGM) devices represent the largest and most rapidly expanding segment within diabetes care technology. These devices use sensors inserted under the skin to measure glucose levels in real-time, providing a constant stream of data that allows patients to adjust their insulin dosage and lifestyle choices accordingly. CGMs are particularly valuable for patients with Type 1 diabetes, who require continuous monitoring to avoid severe blood sugar fluctuations. The real-time data offered by CGMs has transformed diabetes management, making it more efficient and personalized.

The dominance of CGMs in the market is attributed to their high accuracy, ability to detect glucose trends, and improved patient outcomes. Additionally, CGMs have gained regulatory approval from major health authorities, such as the U.S. Food and Drug Administration (FDA), further promoting their widespread adoption. The rise of insulin pumps integrated with CGM technology is also enhancing the effectiveness of diabetes management, driving growth in the CGM segment. This combination of features allows for improved glucose control, reduced hypoglycemia risk, and enhanced patient satisfaction.

Homecare Settings Is Fastest Growing End-User Segment Owing To Rising Self-Management Trends

The homecare settings segment is the fastest growing end-user subsegment in the diabetes care devices market. This growth is largely driven by the increasing preference among diabetes patients for managing their condition at home, with minimal intervention from healthcare providers. Homecare diabetes management, particularly through the use of blood glucose monitors, insulin delivery devices, and continuous glucose monitoring systems, offers greater flexibility, convenience, and cost-effectiveness for patients.

The shift towards homecare is supported by technological advancements in remote monitoring and telemedicine, which allow healthcare professionals to provide guidance and oversight remotely. With the increasing adoption of connected diabetes devices and mobile applications that help track and manage blood glucose levels, patients are empowered to take a more active role in their care. Additionally, the rising prevalence of diabetes, particularly Type 2 diabetes, among aging populations has accelerated the demand for homecare diabetes management solutions, making this segment the fastest-growing in the market.

Wearable Devices Segment Is Largest Technology Segment Owing To Patient Convenience

Among the various technological advancements in the diabetes care devices market, wearable devices are the largest and most influential subsegment. Wearable devices, such as smart insulin pumps and continuous glucose monitors, offer significant convenience to patients by allowing them to monitor their condition continuously without the need for traditional, invasive methods. These devices are designed to integrate seamlessly into daily life, providing real-time data, alerts, and automated insulin adjustments to help patients maintain optimal glucose control.

The wearable devices segment continues to dominate due to the growing trend toward remote patient monitoring and the increasing availability of user-friendly, non-invasive glucose monitoring technology. Patients appreciate the convenience of wearable devices, which offer long-term glucose tracking and improve the quality of life for those living with diabetes. These devices also enable healthcare professionals to remotely track patient data, making it easier to adjust treatment plans based on real-time information.

North America Is Largest Region Owing To High Adoption and Advanced Healthcare Infrastructure

North America holds the largest share of the global diabetes care devices market, driven by high adoption rates of advanced diabetes care technologies and well-established healthcare infrastructure. The United States, in particular, is home to a large diabetic population, both Type 1 and Type 2, fueling the demand for diabetes care devices. Furthermore, the region has a high rate of technological innovation and product development in the healthcare sector, which facilitates the rapid introduction and adoption of cutting-edge diabetes management solutions, including continuous glucose monitors, insulin pumps, and wearable devices.

North America’s dominance is also supported by the presence of leading companies in the diabetes care devices market, such as Abbott, Medtronic, and Dexcom. These companies have a strong market presence and offer a broad range of diabetes care devices. Additionally, the region benefits from high levels of healthcare spending, government support for diabetes management programs, and increasing awareness of the importance of managing diabetes effectively, all of which contribute to the market's growth in North America.

Competitive Landscape: Leading Companies Driving Innovation

The competitive landscape of the diabetes care devices market is highly dynamic, with numerous players constantly innovating to meet the growing demand for advanced and efficient diabetes management solutions. Leading companies such as Abbott Laboratories, Medtronic, Dexcom, Roche Diagnostics, and Becton, Dickinson and Company dominate the market. These companies focus heavily on research and development to introduce new products, enhance device accuracy, and improve the overall patient experience.

The market is characterized by strategic partnerships, mergers, and acquisitions, as companies seek to expand their portfolios and strengthen their market positions. For example, Medtronic’s acquisition of Mazor Robotics enhances its diabetes care solutions, while Dexcom continues to innovate with its continuous glucose monitoring systems. As the market continues to grow, companies are also increasingly focusing on integrating digital technologies, such as mobile apps and cloud platforms, with diabetes care devices to provide patients and healthcare providers with real-time insights and improved care management.

List of Leading Companies:

• Medtronic
• Abbott Laboratories
• Roche Diagnostics
• Dexcom
• Becton, Dickinson and Company
• Insulet Corporation
• Johnson & Johnson
• Novo Nordisk
• Sanofi
• Terumo Corporation
• F. Hoffmann-La Roche Ltd
• Tandem Diabetes Care
• Bayer AG
• Eli Lilly and Company
• GlaxoSmithKline (GSK)

Recent Developments:

• Abbott introduced its Freestyle Libre 3, a new continuous glucose monitoring system in Europe, providing real-time glucose data with a smaller, more accurate device.
• Medtronic acquired Mazor Robotics to enhance its surgical robotics offerings, which are expected to complement diabetes care solutions for better patient outcomes.
• Dexcom's G7 CGM system received FDA approval, offering a more compact and accurate glucose monitoring solution for diabetes patients in the U.S.
• Tandem Diabetes Care launched the t:slim X2 insulin pump with Control-IQ technology, enhancing diabetes management for patients with Type 1 diabetes.
• Bayer launched the Contour Next Gen glucose monitoring system, offering improved accuracy and usability for diabetes patients

Report Scope: